This post was originally published on this site
Although the U.S. Supreme Court last week maintained the availability of mifepristone–for now–many legal steps lie ahead to decide the ultimate fate of the abortion pill, and the case has opened the door to other litigation that could undermine the drug approval process and patients’ medication access, experts say.
On Friday, the nation’s highest court granted a request by the Biden administration and mifepristone manufacturer Danco Laboratories to put on hold a lower court’s ruling that suspended the abortion pill’s Food…
